価格表

在庫・価格 : 2024年04月29日 18時26分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Collagen IV, Mouse, ELISA Kit <Collagen IV M ELISA Kit>
データシート
1014 EXOエクソセル
EXOCELL Division of Ethos Biosciences, Inc.
1 kit 本製品は取扱中止になりました 追加

在庫・価格 : 2024年04月29日 18時26分 現在

Collagen IV, Mouse, ELISA Kit <Collagen IV M ELISA Kit>

  • 商品コード:1014
  • メーカー:EXO
  • 包装:1kit
  • 本製品は取扱中止になりました
使用文献
No. 文献情報 備考 参照
1 Kamoun WS et al. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J. Clin. Oncol. 2009 May;27(15):2542-52
Kamoun WS et al
2009/01/01
PubMed
2 Gong Y et al. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 2008 Sep;118(9):3012-24
Gong Y et al
2008/01/01
PubMed
3 Ayers M et al. Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist. Cancer Res. 2007 Jul;67(14):6899-906
Ayers M et al
2007/01/01
PubMed
4 Kobayashi T et al. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int. 2003 Nov;64(5):1632-42
Kobayashi T et al
2003/01/01
PubMed
5 Giunti S et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008 Jan;51(1):198-207
Giunti S et al
2008/01/01
PubMed
6 Bello E et al. The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts. Mol. Cancer Ther. 2013 Feb;12(2):131-40
Bello E et al
2013/01/01
PubMed
7 Sood V et al. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb. Haemost. 2010 Dec;104(6):1174-83
Sood V et al
2010/01/01
PubMed
8 Han M et al. Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A. Free Radic. Biol. Med. 2010 Jan;48(1):128-35
Han M et al
2010/01/01
PubMed
9 Sharma NS et al. Adipocyte-derived basement membrane extract with biological activity: applications in hepatocyte functional augmentation in vitro. FASEB J. 2010 Jul;24(7):2364-74
Sharma NS et al
2010/01/01
PubMed
10 Baader M et al. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. Br. J. Pharmacol. 2018 02;175(4):693-707
Baader M et al
2018/01/01
PubMed
11 Yin MC et al. Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice. Mol Nutr Food Res 2007 May;51(5):572-9
Yin MC et al
2007/01/01
PubMed
12 Soni H et al. Urotensin II-induced store-operated Ca<sup>2+</sup> entry contributes to glomerular mesangial cell proliferation and extracellular matrix protein production under high glucose conditions. Sci Rep 2017 12;7(1):18049
Soni H et al
2017/01/01
PubMed
13 Baldwin JF et al. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J. Vasc. Surg. 2012 Oct;56(4):1089-97
Baldwin JF et al
2012/01/01
PubMed
14 Tsai SJ et al. Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J. Agric. Food Chem. 2012 Jan;60(1):514-21
Tsai SJ et al
2012/01/01
PubMed
15 Kajikawa S et al. Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet. Dig. Dis. Sci. 2011 Apr;56(4):1065-74
Kajikawa S et al
2011/01/01
PubMed
16 Kajikawa S et al. Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats. Dig. Dis. Sci. 2010 Mar;55(3):631-41
Kajikawa S et al
2010/01/01
PubMed
17 Cohen MP et al. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol. Cell. Biochem. 1995 Oct;151(1):61-7
Cohen MP et al
1995/01/01
PubMed
18 Cohen MP et al. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy. Ophthalmic Res. 2008;40(1):5-9
Cohen MP et al
2008/01/01
PubMed
19 Kobayashi M et al. Measurement of mouse urinary type IV collagen using time-resolved fluoroimmunoassay. Anal Sci 2003 Feb;19(2):205-10
Kobayashi M et al
2003/01/01
PubMed
20 Wiedmeyer CE et al. Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease. Comp. Med. 2010 Dec;60(6):448-54
Wiedmeyer CE et al
2010/01/01
PubMed
21 Abo El Gheit R et al. Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats. Physiol Int 2016 Dec;103(4):413-427
Abo El Gheit R et al
2016/01/01
PubMed
22 S叩nchez-L坦pez E et al. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am. J. Physiol. Renal Physiol. 2008 Jan;294(1):F149-60
S叩nchez-L坦pez E et al
2008/01/01
PubMed
23 Nitta K et al. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR&#x2009;&#x2265;&#x2009;30&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>. Clin. Exp. Nephrol. 2019 Aug;23(8):1004-1012
Nitta K et al
2019/01/01
PubMed
24 Bhatt K et al. Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 08;27(8):2277-88
Bhatt K et al
2016/01/01
PubMed
25 Zhang H et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am. J. Physiol. Renal Physiol. 2010 Jul;299(1):F91-8
Zhang H et al
2010/01/01
PubMed
  • No.: 1
  • 文献情報:
    Kamoun WS et al. Edema control by cediranib, a vascular endothelial growth factor receptor-targeted kinase inhibitor, prolongs survival despite persistent brain tumor growth in mice. J. Clin. Oncol. 2009 May;27(15):2542-52
    Kamoun WS et al
    2009/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Gong Y et al. Inflammatory macrophage migration requires MMP-9 activation by plasminogen in mice. J. Clin. Invest. 2008 Sep;118(9):3012-24
    Gong Y et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ayers M et al. Discovery and validation of biomarkers that respond to treatment with brivanib alaninate, a small-molecule VEGFR-2/FGFR-1 antagonist. Cancer Res. 2007 Jul;67(14):6899-906
    Ayers M et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kobayashi T et al. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int. 2003 Nov;64(5):1632-42
    Kobayashi T et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Giunti S et al. Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells. Diabetologia 2008 Jan;51(1):198-207
    Giunti S et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Bello E et al. The tyrosine kinase inhibitor E-3810 combined with paclitaxel inhibits the growth of advanced-stage triple-negative breast cancer xenografts. Mol. Cancer Ther. 2013 Feb;12(2):131-40
    Bello E et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Sood V et al. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism. Thromb. Haemost. 2010 Dec;104(6):1174-83
    Sood V et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Han M et al. Ascorbate protects endothelial barrier function during septic insult: Role of protein phosphatase type 2A. Free Radic. Biol. Med. 2010 Jan;48(1):128-35
    Han M et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Sharma NS et al. Adipocyte-derived basement membrane extract with biological activity: applications in hepatocyte functional augmentation in vitro. FASEB J. 2010 Jul;24(7):2364-74
    Sharma NS et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Baader M et al. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. Br. J. Pharmacol. 2018 02;175(4):693-707
    Baader M et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Yin MC et al. Antiinflammatory and antifibrogenic effects of s-ethyl cysteine and s-methyl cysteine in the kidney of diabetic mice. Mol Nutr Food Res 2007 May;51(5):572-9
    Yin MC et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Soni H et al. Urotensin II-induced store-operated Ca<sup>2+</sup> entry contributes to glomerular mesangial cell proliferation and extracellular matrix protein production under high glucose conditions. Sci Rep 2017 12;7(1):18049
    Soni H et al
    2017/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Baldwin JF et al. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis. J. Vasc. Surg. 2012 Oct;56(4):1089-97
    Baldwin JF et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Tsai SJ et al. Anti-inflammatory and antifibrotic effects of naringenin in diabetic mice. J. Agric. Food Chem. 2012 Jan;60(1):514-21
    Tsai SJ et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Kajikawa S et al. Eicosapentaenoic acid attenuates progression of hepatic fibrosis with inhibition of reactive oxygen species production in rats fed methionine- and choline-deficient diet. Dig. Dis. Sci. 2011 Apr;56(4):1065-74
    Kajikawa S et al
    2011/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Kajikawa S et al. Highly purified eicosapentaenoic acid ethyl ester prevents development of steatosis and hepatic fibrosis in rats. Dig. Dis. Sci. 2010 Mar;55(3):631-41
    Kajikawa S et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Cohen MP et al. Albumin modified by Amadori glucose adducts activates mesangial cell type IV collagen gene transcription. Mol. Cell. Biochem. 1995 Oct;151(1):61-7
    Cohen MP et al
    1995/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 18
  • 文献情報:
    Cohen MP et al. Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy. Ophthalmic Res. 2008;40(1):5-9
    Cohen MP et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 19
  • 文献情報:
    Kobayashi M et al. Measurement of mouse urinary type IV collagen using time-resolved fluoroimmunoassay. Anal Sci 2003 Feb;19(2):205-10
    Kobayashi M et al
    2003/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 20
  • 文献情報:
    Wiedmeyer CE et al. Urinary biomarkers for monitoring disease progression in the Han:SPRD-cy rat model of autosomal-dominant polycystic kidney disease. Comp. Med. 2010 Dec;60(6):448-54
    Wiedmeyer CE et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 21
  • 文献情報:
    Abo El Gheit R et al. Targeting heme oxygenase-1 in early diabetic nephropathy in streptozotocin-induced diabetic rats. Physiol Int 2016 Dec;103(4):413-427
    Abo El Gheit R et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 22
  • 文献情報:
    S叩nchez-L坦pez E et al. Inhibitory effect of interleukin-1beta on angiotensin II-induced connective tissue growth factor and type IV collagen production in cultured mesangial cells. Am. J. Physiol. Renal Physiol. 2008 Jan;294(1):F149-60
    S叩nchez-L坦pez E et al
    2008/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 23
  • 文献情報:
    Nitta K et al. N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR&#x2009;&#x2265;&#x2009;30&#xA0;ml/min/1.73&#xA0;m<sup>2</sup>. Clin. Exp. Nephrol. 2019 Aug;23(8):1004-1012
    Nitta K et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 24
  • 文献情報:
    Bhatt K et al. Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy. J. Am. Soc. Nephrol. 2016 08;27(8):2277-88
    Bhatt K et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 25
  • 文献情報:
    Zhang H et al. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am. J. Physiol. Renal Physiol. 2010 Jul;299(1):F91-8
    Zhang H et al
    2010/01/01
  • 備考:
  • 参照:
    PubMed